Article info

Download PDFPDF

Research paper
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

Authors

  1. Correspondence to Dr Giuseppe Lauria, 3rd Neurology Unit, Department of Clinical Neurosciences, IRCCS Foundation, “Carlo Besta” Neurological Institute, Via Celoria, 11-20133 Milan, Italy; glauria{at}istituto-besta.it
View Full Text

Citation

Lauria G, Dalla Bella E, Antonini G on behalf of the EPOS Trial Study Group, et al
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

Publication history

  • Received July 15, 2014
  • Revised August 26, 2014
  • Accepted September 14, 2014
  • First published January 16, 2015.
Online issue publication 
July 14, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.